LOG IN
SIGN UP
MARKET
APYX
APYX
Apyx Medical Corporation
NASDAQ
Real-time Quotes | Nasdaq Last Sale
6.27
+0.65
+11.57%
After Hours: 6.40 +0.13 +2.07% 19:56 05/27 EDT
OPEN
5.43
PREV CLOSE
5.62
HIGH
6.40
LOW
5.20
VOLUME
3.25M
TURNOVER
0
52 WEEK HIGH
17.50
52 WEEK LOW
3.010
MARKET CAP
216.02M
P/E (TTM)
-13.2895
1D
5D
1M
3M
1Y
5Y
Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction
The U.S. Food and Drug Administration (FDA) announced 510(k) clearance (pre-market notification) of Apyx Medical’s (NASDAQ: APYX) Renuvion Dermal Handpiece for specific dermal resurfacing procedures.
Benzinga · 2d ago
Why Are Apyx Medical Shares Trading Higher Today?
Benzinga · 2d ago
Sector Update: Health Care
MT Newswires · 2d ago
Apyx Medical gains as FDA clears Renuvion for wrinkle reduction
The shares of Apyx Medical (NASDAQ:APYX) added ~6% in the pre-market Thursday after the medical device maker announced that the FDA granted 510(k) clearance for the use of its Renuvion cosmetic
Seekingalpha · 2d ago
BRIEF-Apyx Medical Receives FDA 510(K) Clearance For Renuvion Cosmetic Technology In Dermal Resurfacing Procedures
reuters.com · 2d ago
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
CLEARWATER, Fla., May 26, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical markets, today announced...
Business Wire · 2d ago
Apyx Medical Receives FDA 510(k) Clearance for Renuvion Dermal Handpiece; Shares Rise at Open
MT Newswires · 2d ago
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
CLEARWATER, Fla., May 25, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical markets, announced today...
Business Wire · 2d ago
No Data
Learn about the latest financial forecast of APYX. Analyze the recent business situations of Apyx Medical Corporation through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 3 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average APYX stock price target is 11.33 with a high estimate of 16.00 and a low estimate of 6.00.
Current 6.27
EPS
Actual
Estimate
-0.14-0.10-0.07-0.03
Institutional Holdings
Institutions: 114
Institutional Holdings: 21.89M
% Owned: 63.54%
Shares Outstanding: 34.45M
TypeInstitutionsShares
Increased
21
248.26K
New
8
569.07K
Decreased
31
489.66K
Sold Out
7
102.68K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Non-Executive Chairman/Independent Director
Andrew Makrides
Chief Executive Officer/Director
Charles Goodwin
Non-Executive Vice Chairman/Independent Director
John Andres
Chief Financial Officer/Treasurer/Secretary
Tara Semb
Executive Vice President
Todd Hornsby
Senior Vice President
Moshe Citronowicz
Lead Director/Independent Director
Lawrence Waldman
Director
Wendy Levine
Independent Director
Minnie Baylor-Henry
Independent Director
Michael Geraghty
Independent Director
Craig Swandal
No Data
No Data
About APYX
Apyx Medical Corporation is an advanced energy technology company. It operates through two segments: Advanced Energy and original equipment manufacturer (OEM). The Company designs, develops and manufactures electrosurgical equipment by producing generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with energy-based designs. The Company's Helium Plasma Technology is focused on bringing transformative solutions to the physicians and patients it serves. Its Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with virtually eliminating unintended tissue trauma.
Webull offers kinds of Apyx Medical Corp stock information, including NASDAQ:APYX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APYX stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading APYX stock methods without spending real money on the virtual paper trading platform.